India, Jan. 12 -- Lucknow - In an era where diversified business models are reshaping India's entrepreneurial landscape, few visionaries demonstrate the breadth and depth of innovation seen in the Oikoshreem Group. Spearheaded by Dr. Saubhagya Vardhan, this multifaceted conglomerate has established itself as a formidable force across real estate, renewable energy, healthcare, financial services, infrastructure, and information technology sectors.​The Architect Behind the VisionDr. Saubhagy...
India, Jan. 12 -- India's stock market education landscape is crowded with courses, content creators, and quick-learning promises. Yet, despite unprecedented access to information, a majority of aspiring traders fail to sustain themselves in live markets.The reason is not intelligence or effort.The reason is afundamental gap in how trading is taught.Most institutes teachwhat to trade. Very few teachhow to become a trader.This is the gapStockSprint was built to address.Why Traditional Trading Edu...
Tokyo, Jan. 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060251) titled 'A Network Meta-analysis of Angiotensin Receptor-Neprilysin Inhibitors and Cancer Risk Based on Parallel-Group Individual Randomized Controlled Trials' on Jan. 12. Study Type: Others,meta-analysis etc Primary Sponsor: Institute - Yokohama City University Graduate School of Medicine Condition: Condition - Hypertension, Coronary artery disease, Heart failure, Chronic kidn...
Tokyo, Jan. 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060325) titled 'Clinical results of romosozumab in the treatment of osteoporosis' on Jan. 12. Study Type: Observational Primary Sponsor: Institute - Niimi orthopaedics clinic Condition: Condition - Osteoporosis Classification by malignancy - Others Genomic information - NO Objective: Narrative objectives1 - To clarify the treatment outcomes of romosozumab in real-world clinical pract...
Tokyo, Jan. 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060324) titled 'Clinical results of SERM in the treatment of osteoporosis' on Jan. 12. Study Type: Observational Primary Sponsor: Institute - Niimi orthopaedics clinic Condition: Condition - Osteoporosis Classification by malignancy - Others Genomic information - NO Objective: Narrative objectives1 - To clarify the treatment outcomes of SERM in real-world clinical practice. Basic obj...
Tokyo, Jan. 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060212) titled 'Pemafibrate-Low-Density Lipoprotein Cholesterol Intervention Study' on Jan. 12. Study Type: Observational Primary Sponsor: Institute - Kindai University Condition: Condition - hyperlipidemia Classification by malignancy - Others Genomic information - NO Objective: Narrative objectives1 - The objective of this study is to evaluate the effect of pemafibrate on LDL-C lev...
Tokyo, Jan. 11 -- Financial Services Agency - Tokyo has issued a Notice of Procurement (Goods & Services) on Jan 09, 2026. Here are other related details: Classification: 0027 Computer Services 0071 Computer & Related Services Summary: ⑴ Official in charge of disbursement of the procuring entity : YAGI Mizue, Director of the Resources Management Division, Strategy Development and Management Bureau, Financial Services Agency ⑵ Classification of the products to be procured : 71, ...
Tokyo, Jan. 11 -- Digital Agency - Tokyo has issued a Notice of Procurement (Goods & Services) on Jan 09, 2026. Here are other related details: Classification: 0027 Computer Services 0071 Computer & Related Services Summary: ⑴ Official in charge of disbursement of the procuring entity : TANABE Kuniharu, Counsellor of the Accounts Division, Digital Agency ⑵ Classification of the services to be procured : 71, 27 ⑶ Nature and quantity of the Services to be required : Operati...
Tokyo, Jan. 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060309) titled 'A Randomized Open-Label Crossover Trial on the Effects of Pre-Meal Intake of Fermented Foods on Dietary Intake' on Jan. 11. Study Type: Interventional Study Design: Basic Design - Cross-over Randomization - Randomized Blinding - Open -no one is blinded Control - No treatment Primary Sponsor: Institute - KSO corporation Condition: Condition - None Classification by mal...
Tokyo, Jan. 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059969) titled 'Efficacy test of the body care product for dry skin of the shins' on Jan. 11. Study Type: Interventional Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Single blind -participants are blinded Control - Placebo Primary Sponsor: Institute - Kao Corporation Condition: Condition - Not applicable Classification by malignancy - Others Genomic inf...